Muri, Switzerland

Hans-Peter Strebel

USPTO Granted Patents = 18 


Average Co-Inventor Count = 2.1

ph-index = 17

Forward Citations = 1,018(Granted Patents)


Location History:

  • Muri, CH (2001 - 2014)
  • Lucerne, CH (2005 - 2015)

Company Filing History:


Years Active: 2001-2015

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovative Contributions of Hans-Peter Strebel in Pharmaceutical Patents

Introduction

Hans-Peter Strebel, a prominent inventor based in Muri, Switzerland, has made significant strides in the pharmaceutical field, holding a remarkable total of 18 patents. His work primarily focuses on innovative treatments for cardiac insufficiency and asthma, utilizing fumaric acid derivatives to develop novel medicinal applications.

Latest Patents

Among his most recent patents, Hans-Peter Strebel has explored the use of fumaric acid derivatives for treating cardiac insufficiency and asthma. The first patent discusses the preparation of drugs using various fumaric acid derivatives, including dialkyl fumarates and monoalkyl hydrogen fumarates, specifically targeting conditions such as left ventricular insufficiency, myocardial infarction, and angina pectoris. The second patent addresses the treatment of asthma and chronic obstructive pulmonary diseases, highlighting the effectiveness of fumaric acid derivatives in managing asthma triggered by various factors, including allergies and physical exertion. Additionally, his research includes the use of dialkyl fumarates in transplantation medicine and autoimmune disease therapies, emphasizing the integration of these compounds in micro-tablet or pellet forms.

Career Highlights

Throughout his career, Hans-Peter has collaborated with leading pharmaceutical companies, including Biogen Idec International GmbH and Fumapharm AG. His contributions to these organizations have been instrumental in the advancement of innovative therapeutic options in the medical field.

Collaborations

Hans-Peter Strebel's innovative journey has been enriched by collaborations with esteemed professionals in the industry, such as Rajendra Kumar Joshi and Jitka Ulrichová. These partnerships have facilitated the exchange of ideas and expertise, fostering an environment of creativity and breakthrough innovations.

Conclusion

With a commitment to enhancing patient outcomes through innovative drug development, Hans-Peter Strebel stands out as a dedicated inventor in the pharmaceutical sector. His 18 patents reflect not only his inventive spirit but also his contributions toward addressing pressing health issues such as cardiac insufficiency and asthma, paving the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…